Shares of Innophos Holdings Inc. (NASDAQ:IPHS) fell 3% on Wednesday . The company traded as low as $40.34 and last traded at $40.76, with a volume of 91,437 shares. The stock had previously closed at $42.00.

Separately, Zacks Investment Research lowered Innophos Holdings from a “strong-buy” rating to a “hold” rating in a report on Wednesday.

The firm has a 50 day moving average price of $40.00 and a 200-day moving average price of $32.75. The company has a market capitalization of $795.12 million and a P/E ratio of 30.09.

Innophos Holdings (NASDAQ:IPHS) last announced its quarterly earnings results on Wednesday, April 27th. The company reported $0.66 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.42 by $0.24. During the same quarter in the prior year, the business earned $0.55 EPS. The firm had revenue of $189.60 million for the quarter, compared to analyst estimates of $189.90 million. The firm’s quarterly revenue was down 6.0% on a year-over-year basis. Equities research analysts forecast that Innophos Holdings Inc. will post $2.52 EPS for the current year.

In other news, VP Joseph Golowski sold 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 22nd. The shares were sold at an average price of $40.46, for a total transaction of $202,300.00. Following the completion of the sale, the vice president now owns 28,069 shares in the company, valued at approximately $1,135,671.74. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Robert J. Zatta purchased 1,000 shares of the business’s stock in a transaction dated Tuesday, May 24th. The shares were purchased at an average price of $37.11 per share, with a total value of $37,110.00. Following the acquisition, the director now directly owns 4,351 shares in the company, valued at $161,465.61. The disclosure for this purchase can be found here.

A number of hedge funds recently bought and sold shares of the stock. California State Teachers Retirement System increased its stake in Innophos Holdings by 1.5% in the fourth quarter. California State Teachers Retirement System now owns 36,423 shares of the company’s stock valued at $1,056,000 after buying an additional 539 shares during the period. Rhumbline Advisers increased its stake in Innophos Holdings by 2.9% in the fourth quarter. Rhumbline Advisers now owns 44,905 shares of the company’s stock valued at $1,301,000 after buying an additional 1,245 shares during the period. Robeco Institutional Asset Management B.V. increased its stake in Innophos Holdings by 3.0% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 49,144 shares of the company’s stock valued at $1,424,000 after buying an additional 1,444 shares during the period. Barrow Hanley Mewhinney & Strauss LLC bought a new stake in Innophos Holdings during the fourth quarter valued at $1,444,000. Finally, Nationwide Fund Advisors increased its stake in Innophos Holdings by 31.9% in the fourth quarter. Nationwide Fund Advisors now owns 87,940 shares of the company’s stock valued at $2,549,000 after buying an additional 21,245 shares during the period.

Innophos Holdings, Inc is a producer of performance-critical and nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. Bioactive mineral ingredients are mineral based ingredients for food, beverage and dietary supplement end markets that are manufactured to be readily digestible.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.